Skip to main content
Clinical Trials/CTRI/2018/07/014892
CTRI/2018/07/014892
Completed
Phase 4

se of intralesional injection of triamcinolone with hyaluronidase and triamcinolone alone in treatment of keloid:a comparative study

Dr Prasanta Bhattacharya0 sites90 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Keloid
Sponsor
Dr Prasanta Bhattacharya
Enrollment
90
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Prasanta Bhattacharya

Eligibility Criteria

Inclusion Criteria

  • Keloid lesion of size 2\-5 cm

Exclusion Criteria

  • Patients having allergy to Hyaluronidase or Triamcinolone, Pregnant patients,Patients with ITP, patients with secondary infection in and around keloid.

Outcomes

Primary Outcomes

Not specified

Similar Trials